Estados financieros detallados de Aethlon Medical, Inc. (AEMD): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $1.43, AEMD presenta beneficios negativos (P/E no significativo) y un ROE del -123.09%. La capitalización bursátil es de $1M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Ingresos | $392073 | $149625 | $229625 | $650187 | $659104 | $294165 | $574245 | 0 | 0 | 0 |
| Coste de Ventas | 0 | $2.63B | $3.08B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$3.09B | -$2.49B | -$2.85B | $650187 | $659104 | $294165 | $574245 | 0 | 0 | 0 |
| I+D | $673000 | $586000 | $896000 | $927000 | $2.1M | $2.3M | $2.7M | $2.5M | $2.2M | $1.9M |
| Generales y Administrativos | $6.5M | $5.0M | $6.2M | $6.6M | $8.6M | $10.7M | $12.5M | $12.6M | $9.3M | $7.3M |
| Gastos Operativos | $6.5M | $5.0M | $6.2M | $6.6M | $8.6M | $10.7M | $12.5M | $12.6M | $9.3M | $7.3M |
| Beneficio Operativo | -$6.1M | -$4.8M | -$6.0M | -$5.9M | -$7.9M | -$10.4M | -$11.9M | -$12.6M | -$9.3M | -$7.3M |
| EBITDA | -$7.0M | -$5.3M | -$6.0M | -$5.9M | -$7.9M | -$10.3M | -$11.8M | -$11.8M | -$13.0M | -$6.8M |
| Gastos por Intereses | $304330 | $361597 | $220487 | $54232 | $1580 | 0 | 0 | 0 | $10109 | $14372 |
| Beneficio Antes de Impuestos | -$7.3M | -$5.7M | -$6.2M | -$6.4M | -$7.9M | -$10.4M | -$12.0M | -$12.2M | -$13.4M | -$7.2M |
| Impuestos | 0 | 0 | -$24785 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$7.3M | -$5.7M | -$6.2M | -$6.4M | -$7.9M | -$10.4M | -$12.0M | -$12.2M | -$13.4M | -$7.2M |
| BPA | $0.00 | $0.00 | $0.00 | $0.00 | $-521.81 | $-564.68 | $-468.60 | $-388.67 | $-85.77 | $-10.61 |
| BPA Diluido | $0.00 | $0.00 | $0.00 | $0.00 | $-521.81 | $-564.68 | $-468.60 | $-388.67 | $-85.77 | $-10.61 |
| Acciones en Circulación (Diluidas) | 0 | 0 | 0 | 0 | $15114 | $18446 | $25672 | $31410 | $156085 | $673945 |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$152946 | -$155516 | -$79547 | 0 |
| Beneficio Operativo | -$1.5M | -$2.1M | -$1.9M | -$1.6M |
| EBITDA | -$1.3M | -$1.9M | -$1.8M | -$1.5M |
| Beneficio Neto | -$1.5M | -$2.0M | -$1.9M | -$1.5M |
| BPA | $-3.74 | $-2.45 | $-1.49 | $-4.02 |
| BPA Diluido | $-3.74 | $-2.45 | $-1.49 | $-4.02 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Caja y Equivalentes | $1.6M | $7.0M | $3.8M | $9.6M | $9.9M | $17.1M | $14.5M | $5.4M | $5.5M | $5.0M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | $74813 | 0 | $206729 | $149082 | $127965 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $1.6M | $7.2M | $4.0M | $10.0M | $10.4M | $18.2M | $15.1M | $6.2M | $5.9M | $5.6M |
| Inmovilizado Material | $29223 | $27552 | $6021 | $276910 | $201339 | $1.1M | $2.3M | $1.9M | $1.3M | $664642 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $84996 | $75832 | $66668 | $57504 | $56954 | $2200 | $1650 | $1100 | $550 | 0 |
| Activos Totales | $1.7M | $7.4M | $4.1M | $10.4M | $10.7M | $19.4M | $17.5M | $8.2M | $7.4M | $6.3M |
| Cuentas por Pagar | $484423 | $124450 | $131931 | $285036 | $337678 | $499962 | $432890 | $777862 | $534524 | $384550 |
| Deuda a Corto | 0 | 0 | $962301 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $611756 | $477957 | $1.8M | $1.1M | $1.4M | $1.8M | $1.5M | $1.8M | $1.9M | $1.4M |
| Deuda a Largo | $519200 | $841153 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.1M | $1.3M | $1.8M | $1.1M | $1.4M | $2.4M | $2.4M | $2.5M | $2.2M | $1.4M |
| Reservas | -$93.8M | -$99.5M | -$105.7M | -$112.0M | -$119.9M | -$130.3M | -$142.4M | -$154.6M | -$168.0M | -$175.1M |
| Patrimonio Neto | $676379 | $6.1M | $2.4M | $9.4M | $9.4M | $17.1M | $15.1M | $5.8M | $5.1M | $4.9M |
| Deuda Total | $519200 | $841153 | $962301 | $141097 | $42543 | $729410 | $1.2M | $940316 | $649751 | $336718 |
| Deuda Neta | -$1.0M | -$6.1M | -$2.9M | -$9.5M | -$9.8M | -$16.3M | -$13.3M | -$4.5M | -$4.9M | -$4.7M |
| Capital Circulante | $985496 | $6.8M | $2.2M | $9.0M | $9.0M | $16.3M | $13.6M | $4.4M | $4.1M | $4.1M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $5.9M | $7.0M | $5.0M | $4.9M |
| Activos Totales | $7.3M | $8.1M | $6.3M | $6.2M |
| Pasivos Totales | $1.6M | $1.3M | $1.4M | $1.0M |
| Patrimonio Neto | $5.7M | $6.7M | $4.9M | $5.2M |
| Deuda Total | $496772 | $417522 | $336718 | $367608 |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Beneficio Neto | -$7.3M | -$5.7M | -$6.2M | -$6.4M | -$7.9M | -$10.4M | -$12.0M | -$12.2M | -$13.4M | -$7.2M |
| Amortizaciones | $32413 | $35658 | $30695 | $26366 | $39939 | $123685 | $240892 | $359057 | $339559 | $323653 |
| Compensación en Acciones | $2.2M | $1.3M | $1.3M | $843998 | $779421 | $750621 | $1.1M | $1.2M | $415234 | $278547 |
| Cambio en Capital Circulante | $457626 | -$293657 | $435877 | -$115003 | $309690 | -$251110 | $65339 | $478659 | $93694 | -$743149 |
| Flujo de Caja Operativo | -$3.5M | -$3.9M | -$4.3M | -$5.2M | -$6.8M | -$9.8M | -$10.5M | -$10.1M | -$7.6M | -$7.0M |
| Inversiones (CapEx) | -$16433 | -$24823 | 0 | -$151665 | -$59881 | -$349193 | -$943109 | -$250867 | $2 | -$3704 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | -$378518 | -$278633 | -$193866 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$3.5M | -$3.9M | -$4.3M | -$5.3M | -$6.8M | -$10.1M | -$11.4M | -$10.4M | -$7.6M | -$7.0M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$1.7M | -$1.9M | -$1.8M | -$1.90B |
| Inversiones (CapEx) | -$3 | 0 | -$2051 | -$9.2M |
| Flujo de Caja Libre | -$1.7M | -$1.9M | -$1.8M | -$1.91B |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $72442 | $72442 | $61221 | $50.0M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Crecimiento Ingresos (anual) | | -61.8% | +53.5% | +183.2% | +1.4% | -55.4% | +95.2% | -100.0% | | |
| Crecimiento Beneficio Neto (anual) | | +21.9% | -9.1% | -2.9% | -23.7% | -32.1% | -15.5% | -1.5% | -9.7% | +46.6% |
| Crecimiento BPA (anual) | | | | | | -8.2% | +17.0% | +17.1% | +77.9% | +87.6% |
| Cambio en Acciones (anual) | | | | | | +22.0% | +39.2% | +22.4% | +396.9% | +331.8% |
| Crecimiento FCF (anual) | | -11.7% | -9.1% | -24.6% | -27.6% | -48.2% | -13.2% | +9.3% | +26.3% | +8.4% |
| Margen Bruto | -787423.3% | -1661027.2% | -1242674.4% | 100.0% | 100.0% | 100.0% | 100.0% | | | |
| Margen Operativo | -1555.3% | -3228.7% | -2612.5% | -912.0% | -1197.3% | -3542.5% | -2072.0% | | | |
| Margen EBITDA | -1777.7% | -3544.2% | -2599.0% | -908.0% | -1191.2% | -3500.5% | -2052.9% | | | |
| Margen Neto | -1855.8% | -3796.2% | -2697.9% | -980.3% | -1196.6% | -3540.9% | -2094.9% | | | |
| Margen FCF | -898.4% | -2630.2% | -1869.8% | -822.7% | -1035.5% | -3439.0% | -1993.6% | | | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | 0.4% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| FCF por Acción | | | | | $-451.56 | $-548.43 | $-445.94 | $-330.49 | $-48.98 | $-10.39 |
| Dividendo por Acción | | | | | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | 0 | 0 | 0 | 0 | $15000 | $18000 | $25000 | $31000 | $156000 | $673000 |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -123.09% |
| Rentabilidad sobre capital invertido | -127.19% |
| Rentabilidad sobre activos | -111.26% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.07 |
| Ratio corriente | 5.42 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -34.28 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| P/E | 0.00 | 0.00 | 0.00 | 0.00 | -15.56 | -10.34 | -3.27 | -1.78 | -1.67 | -1.03 |
| P/VC | 0.00 | 0.00 | 0.00 | 0.00 | 12.92 | 6.14 | 2.54 | 3.72 | 4.36 | 1.51 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 184.80 | 357.35 | 66.61 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | -787423.3% | -1661027.2% | -1242674.4% | 100.0% | 100.0% | 100.0% | 100.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | -1555.3% | -3228.7% | -2612.5% | -912.0% | -1197.3% | -3542.5% | -2072.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | -1855.8% | -3796.2% | -2697.9% | -980.3% | -1196.6% | -3540.9% | -2094.9% | 0.0% | 0.0% | 0.0% |